Posts tagged as: Taglich Brothers back to homepage
 |
Taglich Updates ALR Technologies, Maintains 50 Cent Price Target(0) Analyst firm Taglich Brothers has updated their research report on ALR Technologies (OTCBB: ALRT). The New York-based firm has maintained their 50 cent, 12-month price target on ALRT and “Speculative Buy” rating based on five-year revenue potential for the company. Shares of ALRT closed trading on Wednesday at $0.0795; ahead 13.57% from Tuesday’s closing price. Read More |
 |
Taglich Brothers Analyst Report on ALRT in PowerPoint(0) Leading research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT) with a 12-month price target set at 50 cents. Shares are trading today at 8 cents. ALR maintains a relatively low profile in the investment community, but Taglich apparently sees some substantial upside based on their extensive analyst report. Read More |
|
Taglich Brothers Issues “Speculative Buy” and $0.50 Target on ALR Technologies(0) Research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT); issuing a “Speculative Buy” rating and a $0.50 12-month price target on the healthcare technology company and developer of the Health-e-Connect (HeC) system. HeC is an FDA-cleared Internet-based system from chronic disease management. A scalable technology for a wide array of chronic diseases, HeC is initially being marketed by ALR Technologies as a solution Read More |
OTCBB News
read more
Stay Informed
Dana-Farber to Host Cellceutix Trials
Diabetes Rate Growing Exponentially
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.
